UBS Group Forecasts Strong Price Appreciation for Xometry (NASDAQ:XMTR) Stock

Xometry (NASDAQ:XMTR – Free Report) had its price objective raised by UBS Group from $20.00 to $22.00 in a research note published on Wednesday morning, Benzinga reports. UBS Group currently has a neutral rating on the stock. XMTR has been the topic of several other research reports. Cantor Fitzgerald restated an “underweight” rating and issued […]

Leave a Reply

Your email address will not be published.

Previous post Stoke Therapeutics’ (STOK) Buy Rating Reaffirmed at Needham & Company LLC
Next post Rajeev K. Goel Sells 19,892 Shares of PubMatic, Inc. (NASDAQ:PUBM) Stock